Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
400 participants
INTERVENTIONAL
2009-10-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
In Vitro Human Embryo Culture System
NCT00985218
Clinical Validation of Embryo Cinematography
NCT01549262
Embryo Culture At a Constant Temperature of 36.6°C or 37.1°C
NCT03548532
Intrauterine Embryo Development With ANECOVA Device
NCT00480103
Comparison of Alternative Embryo Culture Systems
NCT02028897
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Static culture
Embryos individually cultured in microdrops of 40 microliters of G-IVFplus series V
Static culture
Embryos cultured in 40 microliters microdrops of G-IVF plus series V
Smart plataform
Embryos culture in dynamics microfluidic culture system
SMART dynamic system of embryo culture
Embryos will be cultured in a dynamic system of microfluidics.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SMART dynamic system of embryo culture
Embryos will be cultured in a dynamic system of microfluidics.
Static culture
Embryos cultured in 40 microliters microdrops of G-IVF plus series V
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No more than 1 previous IVF failure
* Absence of physical conditions that can interfere in oocyte quality
* At least 8 zigotes 24 hours after fertilization
Exclusion Criteria
* Sperm or egg donation
* Untreated systemic diseases
21 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Incept Biosystems
UNKNOWN
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Universidade Federal de São Paulo
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eduardo LA Motta, MD, PhD
Role: STUDY_CHAIR
Department of Gynecology - Universidade Federal de Sao Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Departamento de Ginecologia
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0405/08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.